Xenon Pharmaceuticals
XENE
XENE
215 hedge funds and large institutions have $3.39B invested in Xenon Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 66 increasing their positions, 71 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
7% less repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 71
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
28% less call options, than puts
Call options by funds: $10.2M | Put options by funds: $14.1M
Holders
215
Holding in Top 10
9
Calls
$10.2M
Puts
$14.1M
Top Buyers
| 1 | +$57.6M | |
| 2 | +$33.7M | |
| 3 | +$21M | |
| 4 |
Millennium Management
New York
|
+$20.1M |
| 5 |
CP
Caligan Partners
New York
|
+$17.8M |
Top Sellers
| 1 | -$36.1M | |
| 2 | -$23.9M | |
| 3 | -$21.2M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$18.3M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$16.4M |
